Skip to content

SENESTECH, INC.

NASDAQ: SNES

Company: SenesTech, Inc.
Ticker: Nasdaq: SNES
Sector: Industrials
Investor Contact: Robert Blum

SenesTech, Inc.

Stock Detail

Nasdaq CM:SNES
$1.64
04/03/2025 4:03 PMET
Change
$-0.16(-8.66%)
Volume
67,623
Today's Open
$1.79
Previous Close
$1.79
Outstanding
1,746,930
Today's High
$1.84
Today's Low
$1.57
52 Week High
$9.80
52 Week Low
$1.57
Market Cap
$2.856 M
Company Description
SenesTech is committed to improving the health of the world by humanely managing animal pest populations through fertility control. The Company invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, and Evolve, an EPA-designated minimum-risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. SenesTech strives for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable. For more information visit https://senestech.com/ and https://contrapeststore.com.

Videos

SenesTech (SNES) Fireside Chat

SenesTech (SNES) Fireside Chat

During this fireside chat we welcome SenesTech (Nasdaq: SNES). SenesTech is committed to improving the health of the world by humanely managing animal pest populations through fertility control. They are experts in fertility control to manage animal pest populations....

read more
SenesTech (SNES) Company Webcast

SenesTech (SNES) Company Webcast

SenesTech, Inc. (Nasdaq: SNES) is committed to improving the health of the world by humanely managing animal pest populations through its expertise in fertility control. The Company's products include ContraPest®, the only U.S. EPA-registered contraceptive for male...

read more
SenesTech, Inc. (SNES) Company Webcast

SenesTech, Inc. (SNES) Company Webcast

I'm extremely pleased to welcome SenesTech, ticker symbol of SNES on the NASDAQ. And joining us today from the company is their Chief Executive Officer, Joel Fruendt and the company's Chief Financial Officer, Tom Chesterman. SenesTech is committed to improving the...

read more

News

Arrow